Fig. 1.
Fig. 1. Adjusted probabilities (from Cox regression model) of survival after diagnosis of CML in persons receiving HLA-identical sibling bone marrow transplants or nontransplant therapy with hydroxyurea or interferon.

Adjusted probabilities (from Cox regression model) of survival after diagnosis of CML in persons receiving HLA-identical sibling bone marrow transplants or nontransplant therapy with hydroxyurea or interferon.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal